| 11428694 |
Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies |
Robert N. Ziemann, April Ahlberg, David J. Hawksworth, A. Scott Muerhoff, Christopher Marohnic +1 more |
2022-08-30 |
$305,810,000 |
| 11421023 |
Anti-GP73 monoclonal antibodies and methods of obtaining the same |
Bailin Tu, Robert N. Ziemann, Philip M. Hemken, Carol S. Ramsay, Carolyn J. Strobel +6 more |
2022-08-23 |
$258,140,000 |
| 10444242 |
Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies |
Robert N. Ziemann, April Ahlberg, David J. Hawksworth, A. Scott Muerhoff, Christopher Marohnic +3 more |
2019-10-15 |
$111,977,000 |
| 10345311 |
Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies |
Robert N. Ziemann, April Ahlberg, David J. Hawksworth, A. Scott Muerhoff, Christopher Marohnic +1 more |
2019-07-09 |
$69,227,000 |
| 10308709 |
Anti-GP73 monoclonal antibodies and methods of obtaining the same |
Bailin Tu, Robert N. Ziemann, Philip M. Hemken, Carol S. Ramsay, Carolyn J. Strobel +6 more |
2019-06-04 |
$132,459,000 |
| 10215754 |
Anti-T. cruzi antibodies and methods of use |
Susan E. Brophy, David J. Hawksworth, Dinesh O. Shah, Robert W. Siegel, Bailin Tu +2 more |
2019-02-26 |
$163,316,000 |
| 10197573 |
HCV core lipid binding domain monoclonal antibodies |
Robert N. Ziemann, April Ahlberg, David J. Hawksworth, A. Scott Muerhoff, Christopher Marohnic +1 more |
2019-02-05 |
$45,873,000 |
| 9482667 |
Anti-T. cruzi antibodies and methods of use |
Susan E. Brophy, David J. Hawksworth, Dinesh O. Shah, Robert W. Siegel, Bailin Tu +2 more |
2016-11-01 |
$35,992,000 |
| 9469686 |
Anti-GP73 monoclonal antibodies and methods of obtaining the same |
Bailin Tu, Robert N. Ziemann, Philip M. Hemken, Carol S. Ramsay, Carolyn J. Strobel +6 more |
2016-10-18 |
$36,659,000 |
| 9371374 |
HCV core lipid binding domain monoclonal antibodies |
Robert N. Ziemann, April Ahlberg, David J. Hawksworth, A. Scott Muerhoff, Christopher Marohnic +1 more |
2016-06-21 |
$133,288,000 |
| 9073984 |
Anti-T. cruzi antibodies and methods of use |
Susan E. Brophy, David J. Hawksworth, Dinesh O. Shah, Robert W. Siegel, Bailin Tu +2 more |
2015-07-07 |
$30,571,000 |
| 8846036 |
Antibodies that bind to mammalian NGAL and uses thereof |
Larry G. Birkenmeyer, Suresh M. Desai, David J. Hawksworth, Edward T. Olejniczak, Qiaoqiao Ruan +7 more |
2014-09-30 |
$14,143,000 |
| 8349325 |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
Susan E. Brophy, Saul Datwyler, David J. Hawksworth, Don C. Laird, Sharmila Manoj +3 more |
2013-01-08 |
$26,270,000 |
| 7998480 |
Human BNP immunospecific antibodies |
Susan E. Brophy, Joan D. Tyner, Bailin Tu, Mary S. Pinkus, Jessie W. Shih |
2011-08-16 |
$18,160,000 |
| 7939069 |
Human BNP immunospecific antibodies |
Susan E. Brophy, Joan D. Tyner |
2011-05-10 |
$62,035,000 |
| 7731965 |
Human ring specific BNP antibodies |
Jessie W. Shih, Joan D. Tyner, Matthew S. Matias, Mary S. Pinkus, Susan E. Brophy +2 more |
2010-06-08 |
|
